203 related articles for article (PubMed ID: 28442599)
1. Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α.
Keremu A; Aini A; Maimaitirexiati Y; Liang Z; Aila P; Xierela P; Tusun A; Moming H; Yusufu A
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 28442599
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
3. Influence of miR-199a on rats with non-small cell lung cancer via regulating the HIF-1α/VEGF signaling pathway.
Wang LM; Zhang LL; Wang LW; Zhu L; Ma XX
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10363-10369. PubMed ID: 31841190
[TBL] [Abstract][Full Text] [Related]
4. microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis.
Yang D; Xu T; Fan L; Liu K; Li G
J Exp Clin Cancer Res; 2020 Sep; 39(1):201. PubMed ID: 32972441
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-33b Inhibits the Proliferation and Migration of Osteosarcoma Cells via Targeting Hypoxia-Inducible Factor-1α.
Zhou Y; Yang C; Wang K; Liu X; Liu Q
Oncol Res; 2017 Mar; 25(3):397-405. PubMed ID: 27662380
[TBL] [Abstract][Full Text] [Related]
6. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
[TBL] [Abstract][Full Text] [Related]
9. [miR-199a-5p inhibits the proliferation of rat airway smooth muscle cells and the expression of hypoxia inducible factor 1 alpha under hypoxia conditions].
Zhang H; Zhu S; Zhang C; Liu W; Zhu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Sep; 31(9):1183-8. PubMed ID: 26359097
[TBL] [Abstract][Full Text] [Related]
10. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).
Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T
Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells.
Liu M; Wang D; Li N
Oncol Res; 2016; 23(5):257-66. PubMed ID: 27098149
[TBL] [Abstract][Full Text] [Related]
12. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
15. miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells.
Jin Y; Wang H; Zhu Y; Feng H; Wang G; Wang S
Eur J Pharmacol; 2020 Jul; 878():173105. PubMed ID: 32278855
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.
Xu K; Zhan Y; Yuan Z; Qiu Y; Wang H; Fan G; Wang J; Li W; Cao Y; Shen X; Zhang J; Liang X; Yin P
Mol Ther; 2019 Oct; 27(10):1810-1824. PubMed ID: 31208913
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.
Adamski J; Price A; Dive C; Makin G
PLoS One; 2013; 8(6):e65304. PubMed ID: 23785417
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
Jia XQ; Cheng HQ; Qian X; Bian CX; Shi ZM; Zhang JP; Jiang BH; Feng ZQ
Cell Biochem Biophys; 2012 Jan; 62(1):237-44. PubMed ID: 21847633
[TBL] [Abstract][Full Text] [Related]
19. MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1α/VEGF pathway.
Dai L; Lou W; Zhu J; Zhou X; Di W
Int J Clin Exp Pathol; 2015; 8(5):4735-44. PubMed ID: 26191163
[TBL] [Abstract][Full Text] [Related]
20. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S
BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
